Study demonstrates that six months of high-impact unilateral exercise significantly improves femoral neck bone density in postmenopausal women without negatively affecting knee osteoarthritis progression.
Risk Adjusted Net Present Value: What is the current valuation of Pfizer’s Osivelotor
The revenue for Osivelotor is expected to reach an annual total of $133 mn by 2040 globally based off GlobalData’s Revenue Model. The drug’s revenue
July 2, 2024